Home Current Issue Previous Issues Published Ahead-of-Print For Authors Journal Info
Skip Navigation LinksHome > About the Journal

About the Journal

Therapeutic Drug Monitoring is a peer-reviewed, multidisciplinary journal directed to an audience of pharmacologists, clinical chemists, laboratorians, pharmacists, drug researchers and toxicologists. It fosters the exchange of knowledge among the various disciplines–clinical pharmacology, pathology, toxicology, analytical chemistry–that share a common interest in Therapeutic Drug Monitoring. The journal presents studies detailing the various factors that affect the rate and extent drugs are absorbed, metabolized, and excreted. Regular features include review articles on specific classes of drugs, original articles, case reports, technical notes, and continuing education articles.

Official Journal of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology

Publication & Editorial Staff Contacts


Publisher
Druanne Martin
druanne.martin@wolterskluwer.com

Production Editor
Lauren Breakstone
Lauren.Breakstone@wolterskluwer.com

Translation, Rights & Licensing
Silvia Serra
translationrights@wolterskluwer.com

LWW Business Offices
2 Commerce Square
2001
Market Street
Philadelphia, PA 19103

Phone: 215-521-8300
www.lww.com

Editors

Gideon Koren, MD, FACMT, FRCPC
Division of Clinical Pharmacology/Toxicology
Hospital for Sick Children
555 University Avenue
Toronto, ON, M5G 1X8
Canada
Phone: 416-813-5781
Fax: 416-813-7562
tdm.journal@sickkids.ca

Prof. Dr. med. Dr. h. c. Michael Oellerich, FFPath (RCPI), FRCPath
Director
Department of Clinical Chemistry/Central Laboratory
University Medical Center Göttingen
George-August-University
Robert-Koch-Str. 40
D-37075 Göttingen, Germany
Phone: 49-551-39-8561
Fax: 49-551-39-8551
moeller@med.uni-goettingen.de

(For North and South America, all manuscripts should be submitted with a cover letter to Gideon Koren, MD, at the above address. From all other regions, manuscripts should be submitted with a cover letter to Prof. Dr. med. Dr. H. C. Michael Oellerich at the above address. Please submit electronically to the above email addresses whenever possible.)

Society Offices

International Association of Therapeutic
Drug Monitoring and Clinical Toxicology
www.iatdmct.org